Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/29240

TítuloGenetic PTX3 deficiency and aspergillosis in stem-cell transplantation
Autor(es)Rodrigues, Fernando José dos Santos
Cunha, Cristina
Aversa, Franco
Lacerda, João F.
Busca, Alessandro
Kunzai, Oliver
Grube, Matthias
Löffler, Jürgen
Maertens, Johan A.
Bell, Alain S.
Inforzato, Antonio
Barbati, Elisa
Almeida, Bruno
Sousa, Pedro Santos e
Barbui, Anna
Potenza, Leonardo
Caira, Morena
Salvatori, Giovanni
Pagano, Livio
Luppi, Mario
Mantovani, Alberto
Velardi, Andrea
Romani, Luigina
Carvalho, Agostinho
Data2014
EditoraMassachusetts Medical Society
RevistaThe New England Journal o F Medicine
Resumo(s)BACKGROUND: The soluble pattern-recognition receptor known as long pentraxin 3 (PTX3) has a nonredundant role in antifungal immunity. The contribution of single-nucleotide polymorphisms (SNPs) in PTX3 to the development of invasive aspergillosis is unknown. METHODS: We screened an initial cohort of 268 patients undergoing hematopoietic stem-cell transplantation (HSCT) and their donors for PTX3 SNPs modifying the risk of invasive aspergillosis. The analysis was also performed in a multicenter study involving 107 patients with invasive aspergillosis and 223 matched controls. The functional consequences of PTX3 SNPs were investigated in vitro and in lung specimens from transplant recipients. RESULTS: Receipt of a transplant from a donor with a homozygous haplotype (h2/h2) in PTX3 was associated with an increased risk of infection, in both the discovery study (cumulative incidence, 37% vs. 15%; adjusted hazard ratio, 3.08; P=0.003) and the confirmation study (adjusted odds ratio, 2.78; P=0.03), as well as with defective expression of PTX3. Functionally, PTX3 deficiency in h2/h2 neutrophils, presumably due to messenger RNA instability, led to impaired phagocytosis and clearance of the fungus. CONCLUSIONS: Genetic deficiency of PTX3 affects the antifungal capacity of neutrophils and may contribute to the risk of invasive aspergillosis in patients treated (Funded by the European Society of Clinical Microbiology and Infectious Diseases and others) .with HSCT.
TipoArtigo
URIhttps://hdl.handle.net/1822/29240
DOI10.1056/NEJMoa1211161
ISSN1533-4406
Versão da editorahttp://www.nejm.org/
Arbitragem científicayes
AcessoAcesso aberto
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
cunha c_n engl j med 2014.pdf726,08 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID